HFS
AZN icon

HL Financial Services’s AstraZeneca AZN Stock Holding History

HL Financial Services’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$296K Sell
3,658
-93
-2% -$7.33K ﹤0.01% 612
2018
Q4 		$285K Buy
3,751
+139
+4% +$10.9K 0.01% 610
2018
Q3 		$286K Buy
3,612
+187
+5% +$14.1K ﹤0.01% 651
2018
Q2 		$241K Sell
3,425
-76
-2% -$5.47K ﹤0.01% 632
2018
Q1 		$245K Sell
3,501
-89
-2% -$6.17K ﹤0.01% 631
2017
Q4 		$249K Buy
3,590
+127
+4% +$8.56K ﹤0.01% 549
2017
Q3 		$235K Sell
3,463
-17,620
-84% -$1.11M ﹤0.01% 619
2017
Q2 		$1.44M Sell
21,083
-2,021
-9% -$132K 0.03% 285
2017
Q1 		$1.44M Buy
23,104
+4,634
+25% +$270K 0.03% 279
2016
Q4 		$1.01M Sell
18,470
-2,593
-12% -$147K 0.02% 319
2016
Q3 		$1.38M Buy
21,063
+791
+4% +$51.7K 0.03% 273
2016
Q2 		$1.22M Buy
20,272
+2,922
+17% +$170K 0.03% 289
2016
Q1 		$977K Buy
17,350
+939
+6% +$56.4K 0.02% 312
2015
Q4 		$1.11M Buy
16,411
+2,275
+16% +$149K 0.03% 292
2015
Q3 		$900K Sell
14,136
-460
-3% -$30.3K 0.03% 303
2015
Q2 		$930K Buy
14,596
+11,595
+386% +$794K 0.02% 323
2015
Q1 		$205K Hold
3,001
– – 0.01% 655
2014
Q4 		$211K Buy
+3,001
New +$215K 0.01% 638
2014
Q2 		– Sell
-7,980
Closed -$518K – 667
2014
Q1 		$518K Sell
7,980
-497
-6% -$32.1K 0.02% 392
2013
Q4 		$503K Buy
+8,477
New +$461K 0.02% 383
2013
Q3 		– Sell
-9,921
Closed -$469K – 581
2013
Q2 		$469K Buy
+9,921
New +$505K 0.02% 349

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HL Financial Services's AZN Position: Q1 2019 in Review

HL Financial Services reduced its AstraZeneca (AZN) stake by 2.5% in Q1 2019, selling an estimated $7.33K and leaving 3,658 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #612.

HL Financial Services first reported a position in AZN in Q2 2013 and has held it in 21 quarters since. The position peaked at $1.44M in Q1 2017. 559 funds tracked by Wall St. Rank hold AZN as of Q1 2019.

  • HL Financial Services held 3,658 shares of AstraZeneca worth $296K as of Q1 2019.
  • HL Financial Services sold 93 AstraZeneca shares in Q1 2019, an estimated $7.33K.
  • AstraZeneca made up ﹤0.01% of HL Financial Services's portfolio in Q1 2019, its #612 holding.
  • HL Financial Services first reported a position in AstraZeneca in Q2 2013 and has held it in 21 quarters since.
  • HL Financial Services's AstraZeneca position peaked at $1.44M in Q1 2017.
  • 559 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2019.

Based on HL Financial Services's 13F filing for Q1 2019, filed 1 May 2019.